PortViewPortView
Neonc Technologies logo

Neonc Technologies (NTHI) Stock Analysis

NASDAQHealthcareBiotechnology

$4.96+4.86%
1-year price historyRange $3.21 – $12.09
52-week range$4.96
$3.01$12.99

What Neonc Technologies does

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Key metrics

Market cap
$128.62M
P/E (TTM)
-4.04
EPS (TTM)
$-1.23
Beta
0.50
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$4.10
200-day avg
$6.59
52-week high
$12.99
52-week low
$3.01
CEO
Amir Farrokh Heshmatpour

ETFs linked to NTHI

Broad-market and Healthcare sector ETFs an investor holding Neonc Technologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NTHI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NTHI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Neonc Technologies?
Neonc Technologies trades under the ticker NTHI on NASDAQ.
Which exchange is NTHI listed on?
NTHI is listed on NASDAQ.
What sector does Neonc Technologies operate in?
Neonc Technologies is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NTHI in a portfolio?
PortView shows NTHI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.